Mereo BioPharma Group Plc (MREO)
0.3798
+0.01
(+3.52%)
USD |
NASDAQ |
Oct 02, 16:00
0.3726
-0.01
(-1.90%)
After-Hours: 20:00
Mereo BioPharma Group Price to Book Value : 2.116 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.116 |
| October 01, 2026 | 2.044 |
| September 30, 2026 | 2.240 |
| September 29, 2026 | 2.079 |
| September 28, 2026 | 2.061 |
| September 25, 2026 | 2.061 |
| September 24, 2026 | 1.880 |
| September 23, 2026 | 1.896 |
| September 22, 2026 | 1.762 |
| September 21, 2026 | 1.616 |
| September 18, 2026 | 1.688 |
| September 17, 2026 | 1.616 |
| September 16, 2026 | 1.482 |
| September 15, 2026 | 1.588 |
| September 14, 2026 | 1.560 |
| September 11, 2026 | 1.560 |
| September 10, 2026 | 1.363 |
| September 09, 2026 | 1.351 |
| September 08, 2026 | 1.418 |
| September 04, 2026 | 1.393 |
| September 03, 2026 | 1.516 |
| September 02, 2026 | 1.489 |
| September 01, 2026 | 1.542 |
| August 31, 2026 | 1.486 |
| August 28, 2026 | 1.407 |
| Date | Value |
|---|---|
| August 27, 2026 | 1.515 |
| August 26, 2026 | 1.549 |
| August 25, 2026 | 1.569 |
| August 24, 2026 | 1.613 |
| August 21, 2026 | 1.618 |
| August 20, 2026 | 1.634 |
| August 19, 2026 | 1.735 |
| August 18, 2026 | 1.744 |
| August 17, 2026 | 1.714 |
| August 14, 2026 | 1.777 |
| August 13, 2026 | 1.714 |
| August 12, 2026 | 1.688 |
| August 11, 2026 | 1.702 |
| August 10, 2026 | 1.518 |
| August 07, 2026 | 1.651 |
| August 06, 2026 | 1.704 |
| August 05, 2026 | 1.691 |
| August 04, 2026 | 1.794 |
| August 03, 2026 | 1.758 |
| July 31, 2026 | 1.909 |
| July 30, 2026 | 1.755 |
| July 29, 2026 | 1.708 |
| July 28, 2026 | 1.724 |
| July 27, 2026 | 1.683 |
| July 24, 2026 | 1.603 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 29.07 |
| BioNTech SE | 1.199 |
| Silence Therapeutics Plc | 14.74 |
| Autolus Therapeutics Plc | 8.446 |
Price to Book Value Related Metrics
| Price | 0.3798 |
| Earnings Yield | -46.13% |
| Market Cap | 60.62M |